AAPP supports access to behavioral interventions, including parent training in behavior management, and stimulant treatment for youth with functionally impairing symptoms of attention-deficit/hyperactivity disorder (ADHD) as the most effective treatment for ADHD given their associated improvement in academic, social, and developmental functioning. Psychiatric pharmacists are encouraged to use this policy brief to support your own advocacy for this gold-standard treatment.